SMC-108

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSMC-108
Drug Alias NameSMC-108
ClassificationBiologics
Mechanisms of ActionFibroblast growth factor receptors agonistsGlycosaminoglycan stimulants
TargetsFibroblast growth factor receptorsGlycosaminoglycan
Therapy Area/IndicationsFractures, BoneWounds and InjuriesImmune System Diseases +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSMC Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSMC Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsFractures, BoneWounds and InjuriesImmune System Diseases +[9] 

Other Information

ATC CodeN/A
Related LinksN/A